EUVIMEDEUVIMED entdecken
Crossref

The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant) Chemotherapy and its Impact as a Prognostic Factor in Early Breast Cancer

Ashraf Zedan

SECI Oncology · 2014

DOI: 10.18056/seci2014.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SECI Oncology, 2014. Verfasst von Ashraf Zedan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zedan, A. (2014). The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant) Chemotherapy and its Impact as a Prognostic Factor in Early Breast Cancer. SECI Oncology. https://doi.org/10.18056/seci2014.10

Vancouver

Zedan A. The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant) Chemotherapy and its Impact as a Prognostic Factor in Early Breast Cancer. SECI Oncology. 2014. doi:10.18056/seci2014.10

BibTeX
@article{Zedan2014,
  author = {Zedan, Ashraf},
  title = {The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant) Chemotherapy and its Impact as a Prognostic Factor in Early Breast Cancer},
  journal = {SECI Oncology},
  year = {2014},
  doi = {10.18056/seci2014.10}
}
Kostenlos starten →